Identifying the location of locoregional recurrences after definitive radiotherapy for head and neck cancer using metabolic parameters of baseline and mid ‐treatment 18F‐FDG‐PET scans

ConclusionThe metabolic parameters of SUV2.5, MTV20% and MTV40% delineated on the baseline and mid-treatment FDG-PET scans encompassed the majority of recurrences. The MTV40% is significantly smaller, hence, we prefer this volume for future dose escalation studies.

Source: Journal of Medical Imaging and Radiation Oncology - October 28, 2022 Category: Radiology Authors: Ewa Aren, Yuvnik Trada, Mark Lee, Shrikant Deshpande, Michael G Jameson, Meredith Johnston, Megan Berry, Vanessa Estall, Allan Fowler Tags: Radiation Oncology —Original Article Source Type: research